Vaatan huviga, et LHVD enimkaubeldud aktsiate nimekirja teisele auhinnalisele kohale on pugenud ENE.
6 kuud tagasi 60bn marketcap’ga firmast, mida peeti uue businessmudeli tekitajaks on täna saanud 8bn marketcap’ga firma, mida elementaarselt ähvardab investment grade staatuses kaotamine, ligipääsu puudumine CP turule ja off-balance sheet tegevuse tulemusena aktsionäride oluline lahjendamine.
Ainuke fundamentaalne põhjus, miks see firma püsima jääb on tema suurus ja olulisus erinevatel kauplemisaladel. Liiga paljudel energiafirmadel on Enroni vastu katmata krediidrisk, et valitsus saaks lubada sellel firmal chapter 11 taga kaitset otsida. Kelle arvelt Enroni krediidikõlblikus taastatakse?? Isiklikult ei kahtle, et aktsionäridel on lootus kaotada samapalju kui GX’s. Kas keegi arvab teisiti?
ma olen seda firmat uurinud viimastel päevadel ja ega need uudised kuigi rõõmsad ei ole jah. siiski arvan, et see firma kord ikkagi tõuseb, kuid ennem tehakse igasugu dilutionit ning muud värgid. põrget võib lähiajal oodata, aga praegu veel ei ostaks
võtsin eile 10 mintsi enne sulgemist positisooni(intuitiivselt:a)alla müüdud b) oli juba ka teistele silma jäänud),
ei tule vist pettuda,
GX ja ENE võrrelda on küll kohatu üks neist on ikka teist aastakümmet juba börsil noteeritud
ei tule vist pettuda,
GX ja ENE võrrelda on küll kohatu üks neist on ikka teist aastakümmet juba börsil noteeritud
ENE puhul on veel lisatrump, et ta on atraktiivne ülevõtmisobjekt, eile räägiti, et RD/SC võiks olla huvitatud, hinnana mainiti 30USD
ENE põrkas peaaegu dollari just.
Jääks pigem selle GX'ga võrdluse juurde, saab olema hea stock daytraderitele, pikaajalised hoidjad ei pruugi põletada mitte näppe, vaid küünarnukke. Btw kannatab GX ja ENE't ka börsil noteerituses võrrelda, vaatasin just, et Rochester Telecom (hilisem Frontier, osa tänasest GX'st) tegi juba apr. 1954 public share issue, mis ei olnud IPO.
ENE tõenäoliselt päeva lõpuks isegi 15-16
Eks iga üks vaatab ise mis sellisest research note`st arvata oskab või millega tegu on... :-)
alljärgnev pärineb 10/25/01 JPM Morning Meeting Research Note`st:
We believe Enron took an important step today in shoring up investor confidence by announcing the appointment of Jeffrey McMahon as its new CFO, replacing Andy Fastow. Despite the reversal from CEO Ken Lay’s statement on ENE’s investor call Tuesday that he had "full confidence in Andy (Fastow)," we think this move should not be interpreted as an admission by ENE that Fastow committed any improprieties. We continue to have full faith in the propriety of Fastow’s involvement with the controversial off-balance sheet financing vehicles, the Marlin and Whitewing (Osprey) trusts. The CFO change simply signals that Lay realized that he needed to bring in fresh management to oversee the rehabilitation of the company’s reputation.
We think McMahon is the right man for the job with an extensive background in Enron’s businesses and an impressive reputation. Jeffrey McMahon has extensive experience within the company, serving as CFO of Enron’s European operations, Treasurer of Enron’s North American business and most recently as head of Enron’s promising and successful Industrial Markets
Division.
Despite this kernel of good news, we expect near-term weakness in Enron’s stock price until Enron fully discloses the underlying assets and liabilities of the Marlin and Whitewing (Osprey) trusts. While appointing a new CFO is a first step in the right direction, we believe it only begins to address the important issues that are of concern to investors. Of much more importance are disclosing the underlying assets and liabilities of the trusts in question and outlining ’worst-case’ scenarios for investors and Enron’s prospective remedies for them.
There is no indication that Enron’s core marketing and trading operations have yet been impeded by the Credit issues facing the Company. We have been given reassurances by ENE’s anagement to this effect and, more importantly, have heard the same about ENE’s operations from many of ENE’s marketing and trading competitors.
alljärgnev pärineb 10/25/01 JPM Morning Meeting Research Note`st:
We believe Enron took an important step today in shoring up investor confidence by announcing the appointment of Jeffrey McMahon as its new CFO, replacing Andy Fastow. Despite the reversal from CEO Ken Lay’s statement on ENE’s investor call Tuesday that he had "full confidence in Andy (Fastow)," we think this move should not be interpreted as an admission by ENE that Fastow committed any improprieties. We continue to have full faith in the propriety of Fastow’s involvement with the controversial off-balance sheet financing vehicles, the Marlin and Whitewing (Osprey) trusts. The CFO change simply signals that Lay realized that he needed to bring in fresh management to oversee the rehabilitation of the company’s reputation.
We think McMahon is the right man for the job with an extensive background in Enron’s businesses and an impressive reputation. Jeffrey McMahon has extensive experience within the company, serving as CFO of Enron’s European operations, Treasurer of Enron’s North American business and most recently as head of Enron’s promising and successful Industrial Markets
Division.
Despite this kernel of good news, we expect near-term weakness in Enron’s stock price until Enron fully discloses the underlying assets and liabilities of the Marlin and Whitewing (Osprey) trusts. While appointing a new CFO is a first step in the right direction, we believe it only begins to address the important issues that are of concern to investors. Of much more importance are disclosing the underlying assets and liabilities of the trusts in question and outlining ’worst-case’ scenarios for investors and Enron’s prospective remedies for them.
There is no indication that Enron’s core marketing and trading operations have yet been impeded by the Credit issues facing the Company. We have been given reassurances by ENE’s anagement to this effect and, more importantly, have heard the same about ENE’s operations from many of ENE’s marketing and trading competitors.
Täna näeme kuidas ENE taas langema hakkab
Enron cut to neutral at Merrill on SEC (ENE)
Merrill Lynch is cutting its recommendation on Enron Corp. (ENE) to a neutral from accumulate and a long-term neutral from a buy after the SEC moved to a formal investigation on the company's dealings into certain related-party transactions. "We believe the timing and directional uncertainty of this new development will at best cap Enron's stock price in the mid-teens while increasing overall volatility," analyst Donato Eassey told clients overnight. The stock is not for the "feint of heart," he says "even with our fundamental analysis intact." Shares were down 44 cents in euro trading to $13.46 ahead of the open in New York Thursday.
Enron cut to neutral at Merrill on SEC (ENE)
Merrill Lynch is cutting its recommendation on Enron Corp. (ENE) to a neutral from accumulate and a long-term neutral from a buy after the SEC moved to a formal investigation on the company's dealings into certain related-party transactions. "We believe the timing and directional uncertainty of this new development will at best cap Enron's stock price in the mid-teens while increasing overall volatility," analyst Donato Eassey told clients overnight. The stock is not for the "feint of heart," he says "even with our fundamental analysis intact." Shares were down 44 cents in euro trading to $13.46 ahead of the open in New York Thursday.
Kas keegi on põrget ka ootamas?
ene puhul peaks toimima loogiak, osta siis kui veri tänaval. Muidugi pole ma keegi, kes suudaks ennustada, kas ta peatub 5, 3 või 1 peal
5'st on juba alla kukkund
uurin ene optsioone :)
riq, jube IV
Implied Volatility on tõesti väga kõrge. Seega kui näiteks mingi uudis tuleb, mis hinna stabiilseks ajab, kukub ka optsiooni väärtus.
ENE-ga korra juba juhtus nii. Aktsia maksis 8 USD - tõusis 10 juurde, kuid kuna IV kukkus, ei saanud calliga midagi teenida.
ENE-ga korra juba juhtus nii. Aktsia maksis 8 USD - tõusis 10 juurde, kuid kuna IV kukkus, ei saanud calliga midagi teenida.
njah,
minu jaoks on parem, kui on optsioonil on suht väike IV, sest siis on lootust, et kasvõi ainult IV tõuseb ja võidad niikuinii. Vastupidisel korral on sul peale suunariski veel ka volatiilsuse vähenemise risk.
Näiteks QQQ volatility oli paar päeva tagasi väga norm, arvatavasti tõuseb see tagasi kõrgemale.
Kõige mõttetum on osta optsioon, kui selle IV on ajalooliselt kõrgeimatel tasemetel. näiteks QQQ peale WTC või sealkandis. Eriti just Leapside puhul.
minu jaoks on parem, kui on optsioonil on suht väike IV, sest siis on lootust, et kasvõi ainult IV tõuseb ja võidad niikuinii. Vastupidisel korral on sul peale suunariski veel ka volatiilsuse vähenemise risk.
Näiteks QQQ volatility oli paar päeva tagasi väga norm, arvatavasti tõuseb see tagasi kõrgemale.
Kõige mõttetum on osta optsioon, kui selle IV on ajalooliselt kõrgeimatel tasemetel. näiteks QQQ peale WTC või sealkandis. Eriti just Leapside puhul.
okei yksasi on IV mis ei arvesta suunda ja teine on yldine arvamus mis toimub.
IV mojutab teoreetilist hinda, tegelik hind soltub ka turumeeleolust.
ma ise vaatan et t6usval turlul ostaes puti kui qqq=38 on see odavam kui langeva turul.
peaks uurima seda, et kui IV on sama aga trend erinev palju on hinnaerinevus..
IV mojutab teoreetilist hinda, tegelik hind soltub ka turumeeleolust.
ma ise vaatan et t6usval turlul ostaes puti kui qqq=38 on see odavam kui langeva turul.
peaks uurima seda, et kui IV on sama aga trend erinev palju on hinnaerinevus..
ENE-l läheb järjest raskemaks. Dynegy võib loobuda diilist põhjendades, et Enron ei andnud finantsolukorrast täit pilti(WSJ)
Veel yks arvamus:
CSFB says its industry contacts and discussions with traders indicate that while trading with ENE has slowed, it certainly has not stopped. Firm continues to believe that ENE is significantly undervalued, despiteits issues, and that ultimately it will trade up in concert with the 0.2685 ratio of the DYN deal.
CSFB says its industry contacts and discussions with traders indicate that while trading with ENE has slowed, it certainly has not stopped. Firm continues to believe that ENE is significantly undervalued, despiteits issues, and that ultimately it will trade up in concert with the 0.2685 ratio of the DYN deal.
keegi veel ene-st huvitub? ma mõtlen, et õige varsti on vist aeg sisenemiseks.